MedTrace Logo

PROFIT - Prostate Fractionated Irradiation Trial

NCT00304759 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 1204

Last updated 2017-07-31

No results posted yet for this study

Summary

This trial is designed to determine whether an 8-week course of escalated dose conformal radiation can be compressed safely, and with similar efficacy into a 4-week course.

Conditions

Interventions

PROCEDURE

7800 cGy/39 fractions in 8 weeks

see above

PROCEDURE

6000 cGy/20 fractions in 4 weeks

see above

Sponsors & Collaborators

  • Canadian Institutes of Health Research (CIHR)

    collaborator OTHER_GOV

  • Trans Tasman Radiation Oncology Group

    collaborator OTHER

  • Ontario Clinical Oncology Group (OCOG)

    lead OTHER

Principal Investigators

  • Charles Catton, MD · Princess Margaret Hospital, Canada

  • Himu Lukka, MD · Juravinski Cancer Centre

  • Mark Levine, MD · Ontario Clinical Oncology Group (OCOG)

  • Jim Julian, MMATH · McMaster University - Department of Oncology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-05-31
Primary Completion
2017-07-15
Completion
2017-07-15

Countries

  • Australia
  • Canada
  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00304759 on ClinicalTrials.gov